Tarsus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
CEOBobak Azamian
CEOBobak Azamian
Employees323
Employees323
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2017
Founded2017
Employees323
Employees323
TARS Key Statistics
Market cap1.81B
Market cap1.81B
Price-Earnings ratio-15.75
Price-Earnings ratio-15.75
Dividend yield—
Dividend yield—
Average volume743.22K
Average volume743.22K
High today$43.42
High today$43.42
Low today$42.47
Low today$42.47
Open price$42.90
Open price$42.90
Volume315.40K
Volume315.40K
52 Week high$57.28
52 Week high$57.28
52 Week low$20.08
52 Week low$20.08
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own TARS. This list is generated using Robinhood data, and it’s not a recommendation.